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The 17S U2 snRNP plays an essential role in branch point selection and catalysis during pre-mRNA splicing.
Much remains to be learned about the molecular architecture of the U2 snRNP, including which proteins
contact the functionally important 5 end of the U2 snRNA. Here, RNA-protein interactions within immuno-
affinity-purified human 17S U2 snRNPs were analyzed by lead(II)-induced RNA cleavage and UV cross-linking.
Contacts between the U2 snRNA and SF3a60, SF3b49, SF3b14a/p14 and SmG and SmB were detected. SF3b49
appears to make multiple contacts, interacting with the 5 end of U2 and nucleotides in loops I and IIb. SF3a60
also contacted different regions of the U2 snRNA, including the base of stem-loop I and a bulge in stem-loop
III. Consistent with it contacting the pre-mRNA branch point adenosine, SF3b14a/p14 interacted with the U2
snRNA near the region that base pairs with the branch point sequence. A comparison of U2 cross-linking
patterns obtained with 17S U2 snRNP versus purified spliceosomal A and B complexes revealed that RNA-
protein interactions with stem-loop I and the branch site-interacting region of U2 are dynamic. These studies
provide important insights into the molecular architecture of 17S U2 snRNPs and reveal U2 snRNP remod-
eling events during spliceosome assembly.
Pre-mRNA splicing is catalyzed by the spliceosome, a large
dynamic macromolecular machinery, which assembles by the
highly coordinated, sequential association of four small nuclear
RNPs (snRNPs) and a large number of non-snRNP protein
splicing factors with conserved sequences of the pre-mRNA
(reviewed in reference 51). A number of spliceosome assembly
intermediates can be detected in vitro by biochemical means.
First, U1 snRNP interacts with the 5 splice site to form the
spliceosomal E (early) complex. The U2 snRNP is weakly
associated with this complex (9), and subsequently it stably
interacts with the branch point sequence (BPS) of the pre-
mRNA in an ATP-dependent fashion, forming complex A. In
the next step the U4/U6.U5 tri-snRNP is incorporated into the
spliceosome, generating complex B. Significant RNA and pro-
tein rearrangements, which lead to destabilization (or re-
lease) of the U1 and U4 snRNPs, generate the catalytically
activated spliceosome (B*) (reviewed in reference 41). The
subsequent catalytic steps of splicing involve two sequential
transesterification reactions (reviewed in reference 51). In
the first step, the branch point adenosine carries out a nu-
cleophilic attack at the 5 splice site, which generates the
cleaved 5 exon and intron 3 exon. In the second, the 3
splice site is cleaved, resulting in the excision of the intron
and ligation of the 5 and 3 exons. The spliced-out intron is
subsequently degraded, and the snRNPs are released to
participate in new rounds of splicing.
The U2 snRNP plays a pivotal role in splicing. It participates
in proper selection and subsequent positioning of the branch
point adenosine (the nucleophile for the first catalytic step)
within the catalytic core of the spliceosome. The U2 snRNA
first establishes a short duplex with the BPS of the intron, in
which the branch adenosine is bulged out (reference 35 and
references therein). It then forms several short duplexes with
the U6 snRNA (e.g., helices I, II, and III) (19, 27, 42). To-
gether with U6, which also base pairs with the 5 splice site, U2
forms part of the RNA network that brings into close proximity
the reactive sites of the pre-mRNA and is thus at the catalytic
core of the spliceosome (reviewed in reference 31).
The human U2 snRNP, which consists of the U2 snRNA and
several proteins, has a modular structure. It was first described
as a 12S particle that consists of the seven Sm proteins, com-
mon to all but the U6 and U6atac spliceosomal snRNPs, and
two U2-specific proteins A and B (reviewed in reference 50).
The splicing-active 17S U2 snRNP additionally contains the
heteromeric splicing factors SF3a and SF3b (2); they consist of
three proteins (SF3a120, SF3a66, and SF3a60) and seven pro-
teins (SF3b155, SF3b145, SF3b130, SF3b49, SF3b14a/p14,
SF3b14b, and SF3b10), respectively (8, 15, 25, 53, 55). SF3a
and SF3b are required for A complex formation (3) and con-
tribute to the selection of the BPS by stabilizing the U2
snRNP-BPS interaction. Components of SF3a and SF3b inter-
act either directly with the branch adenosine (i.e., SF3b14a/
p14) or with a region 25 nucleotides (nt) upstream or 5 nt
downstream of the BPS (15, 16, 53). Due to their close prox-
imity to the branch adenosine, several SF3b proteins are likely
to be core components of the spliceosome. Orthologues of
nearly all SF3a and SF3b components have also been identified
in the yeast Saccharomyces cerevisiae (5, 12, 22, 47). More
recently, a number of other proteins were found to associate
with the human 17S U2 snRNP, the majority of which are
present in substoichiometric amounts (55).
Although a great deal has been learned about the organiza-
tion of components of the U2 snRNP, a complete picture of its
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molecular architecture is currently missing. The core RNP
structure of the U2 snRNP consists of the seven Sm proteins
G, F, E, D1, D2, D3, and B/B that interact with the conserved
Sm site of the U2 snRNA to form a seven-membered ring, the
inner surface of which contacts the Sm site (23, 45). The ma-
jority of U2-specific proteins, including SF3a, SF3b, and U2-
B/U2-A, form stable heteromeric complexes in the absence
of the U2 snRNA. Currently only the U2-B/U2-A het-
erodimer has been shown to directly bind the U2 snRNA,
specifically recognizing stem-loop IV (SLIV) (reviewed in ref-
erence 46). The atomic structure of the human U2-B/U2-A
heterodimer complexed with an RNA hairpin comprising U2
SLIV was determined previously (33).
Recently the three-dimensional structure of purified human
SF3b, the largest U2 subunit, was obtained by single-particle
electron microscopy (13). The relative orientations of several
SF3b proteins and their domains could be determined. In par-
ticular, the SF3b155 C-terminal HEAT repeats are located on
the outer shell of SF3b and curve around the entire complex,
whereas the two RRMs of SF3b49 are found on the periphery
and the SF3b14a/p14 RRM is localized in the central cavity. As
SF3b14a/p14 was shown to directly interact with the branch
point adenosine of pre-mRNA upon stable incorporation of
U2 into the spliceosome (36, 53), SF3b likely undergoes a
dramatic conformational change either upon integration into
the U2 snRNP or during U2 association with the pre-mRNA.
The former is supported by a recent electron cryomicroscopy
study of the U11/U12 di-snRNP. U11 and U12 are the func-
tional counterparts of U1 and U2, respectively, in the minor
U12-type spliceosome that is responsible for splicing a rare
class of pre-mRNA introns (reviewed in reference 32). SF3b
also associates with the U11/U12 di-snRNP (54), and it is
found in a more open conformation in this particle compared
to isolated SF3b (14).
Several protein-protein interactions within the SF3a and
SF3b complexes are well documented, including highly stable
interactions between SF3b155 and SF3b14a/p14 (53), SF3b145
and SF3b49 (6), SF3a120 and SF3a60 (7), and SF3a120 and
SF3a66 (24). However, relatively little is known about how
these functionally important complexes are tethered to the U2
snRNP. Electron microscopy studies suggest that the 17S U2
snRNP consists of two 10- to 12-nm globular domains, of which
one contains SF3b and a 5 portion of the U2 snRNA whereas
the other contains the Sm core, U2-B/U2-A, SF3a, and the 3
part of the U2 snRNA (2, 25).
Here, we have investigated RNA-protein interactions within
the human 17S U2 snRNP. Native human 17S U2 snRNPs,
immunoaffinity purified from HeLa nuclear extract, were ana-
lyzed by RNA cleavage with lead(II) and UV-induced cross-
linking followed by immunoprecipitation and primer extension
analyses. Data from these studies revealed contacts between
the U2 snRNA and SF3a60, SF3b49, and SF3b14a/p14. UV
cross-linking studies with in vitro-reconstituted U2 snRNPs
confirmed an interaction between SF3b49 and the extreme
5 end of the U2 snRNA. Subsequent UV cross-linking with
affinity-purified spliceosomal A and B complexes revealed re-
modeling events involving RNA-protein contacts at the 5 end
of the U2 snRNA upon stable incorporation of the U2 snRNP
into the A complex. Our data thus provide important insight
into the molecular architecture of the 17S U2 snRNP and
reveal that the U2 snRNP is partially remodeled during spli-
ceosome assembly.
MATERIALS AND METHODS
Antibodies. The following rabbit polyclonal antibodies were used in this study:
anti-SF3a120 (directed against a peptide comprising amino acids [aa] 437 to 451)
(53), anti-SF3b155 (aa 99 to 113) (53), anti-SF3b14a/p14 (aa 111 to 125) (53),
anti-SF3a66 (aa 444 to 458) (55) and anti-G (raised against a glutathione
S-transferase–SmG fusion protein) (21). Rabbit anti-SF3a60, anti-SF3b145, and
anti-SF3b49 antibodies and mouse anti-SF3a120 monoclonal antibodies were
generated against peptides DYTDRVKPLQDQNEL, AMTQKYEEHVREQQA,
MAAGPISERNQDATV, and RWLEQRDRSIREKQS (encompassing aa 195
to 209, 816 to 830, 1 to 15, and 437 to 451, respectively). The mouse monoclonal
antibody Ana125 was used to precipitate SmB/B (34). Rabbit antibodies were
affinity purified as described previously (55) and reacted specifically with the
corresponding protein on immunoblots containing HeLa nuclear extract proteins
(data not shown).
Purification of the human 17S U2 snRNP. HeLa cell nuclear extract was
prepared according to the method described in reference 10 and dialyzed against
G150 buffer (20 mM HEPES-KOH, 150 mM KCl, 1.5 mM MgCl2, 5% glycerol,
0.5 mM dithioerythritol, 0.5 mM phenylmethylsulfonyl fluoride, pH 7.9). It was
then diluted with an equal volume of the same buffer and centrifuged at 15,000
 g for 10 min to remove precipitates. The supernatant was passed over an
immunoaffinity chromatography column containing monoclonal mouse antipep-
tide antibodies directed against the SF3a120 protein or polyclonal rabbit anti-
peptide antibodies against the SF3a66 protein (55), covalently coupled to protein
G- or A-Sepharose with dimethylpimelimidate, respectively (52). After extensive
washes, 17S U2 snRNPs were eluted from the column with 3 column volumes of
G150 buffer containing 0.4 mg/ml of the cognate peptide. Purified U2 snRNPs
were fractionated on a 10% to 30% glycerol gradient as described previously
(55). The RNA and protein components of the U2 snRNP were analyzed by
denaturing gel electrophoresis and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), respectively.
In vitro reconstitution of 17S U2 snRNPs. Reconstitution of 17S U2 snRNPs
was performed as described previously (11, 38). Briefly, chimeric U2 snRNA was
prepared by ligation of a synthetic oligoribonucleotide comprising U2 nt 1 to 24
to in vitro-transcribed U2 snRNA encompassing nt 25 to 187 (29). RNAs were
then incubated with native, purified total snRNP proteins in vitro and subse-
quently with HeLa nuclear extract depleted of endogenous 12S U2 snRNPs.
Purification of human spliceosomal A and B complexes. Spliceosomal A and
B complexes formed on MINX pre-mRNA were purified from splicing reactions
by using the previously described tobramycin affinity selection method (18).
Briefly, MINX pre-mRNA containing the J6f1 tobramycin binding RNA
aptamer was first bound to tobramycin covalently coupled to Sepharose and then
incubated with HeLa nuclear extract under splicing conditions for 45 min. Fol-
lowing several wash steps, complexes were eluted from the matrix by incubation
with 5 mM tobramycin. A and B complexes were separated by centrifugation at
374,000  g for 107 min in a TH660 rotor (Sorvall), using a linear 10% to 30%
(vol/vol) glycerol gradient, which was fractionated manually from the top. Frac-
tions 11 to 12 and 15 to 16 were enriched in complexes A and B, respectively.
Additionally, complex B was assembled on a pre-mRNA tagged with three
MS2-binding sites and purified via the MS2-MBP affinity purification method
(9). Briefly, MINX pre-mRNA was prebound with the MS2-MBP fusion protein
and spliceosomes were allowed to form by performing splicing in HeLa nuclear
extract for 8 min. Spliceosomal complexes were fractionated by gradient centrif-
ugation on 10%-to-30% (vol/vol) glycerol gradients (in 20 mM HEPES-KOH
[pH 7.9], 1.5 mM MgCl2, 150 mM NaCl) in a Centrikon TST 41.14 rotor for 16 h
at 80,000  g, and gradient fractions were harvested manually from the top. Peak
gradient fractions containing spliceosomal B complex were pooled and applied to
amylose beads (NEB) preequilibrated with 20 mM HEPES-KOH (pH 7.9), 150
mM NaCl, and 1.5 mM MgCl2. Amylose beads were then washed with 15 column
volumes of preequilibration buffer, and bound spliceosomal B complexes were
eluted with preequilibration buffer containing 12 mM maltose. RNA was recov-
ered from the purified complexes by extraction with phenol:chloroform:isoamy-
lalcohol (PCI), analyzed on a 7 M urea–10% polyacrylamide gel, and visualized
by staining with silver.
Lead(II)-induced U2 snRNA cleavage. 17S U2 snRNPs, and U2 snRNA ex-
tracted from 17S U2 particles with PCI at 4°C, were dialyzed against buffer N1
(20 mM HEPES-NaOH, 5 mM magnesium acetate, 100 mM potassium acetate,
pH 7.5). RNA cleavage was induced by addition of 5 to 45 mM lead(II) acetate
and subsequent incubation for 5 min at 20°C (4). Reactions were terminated by
addition of 50 mM EDTA. Samples were precipitated with ethanol, dissolved in
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PK buffer (100 mM Tris-HCl, 150 mM NaCl, 12.5 mM EDTA, 1% SDS, pH 7.5),
and incubated with 1 mg/ml proteinase K for 1 h at 42°C. Following phenol-
chloroform extraction, RNAs were precipitated twice with ethanol. The RNA
was dissolved in CE buffer (20 mM cacodylic acid-KOH, 0.2 mM EDTA, pH 7.0),
and RNA cleavage sites were analyzed by primer extension.
UV cross-linking of 17S U2 snRNPs, spliceosomal A and B complexes, and
naked U2 snRNA. Approximately 14 pmol of immunoaffinity-purified 17S U2
snRNPs or purified spliceosomal A and B complexes was pipetted in a thin layer
into a 24-well microtiter plate and then subjected to 254 nm UV irradiation for
30 to 120 s on ice essentially as described previously (44). In parallel, U2 snRNA
that had been extracted with PCI from approximately 2 pmol of 17S U2 snRNPs
or spliceosomal complexes at 4°C was cross-linked under the same conditions.
Irradiated and nonirradiated control samples of U2 snRNP and U2 RNA were
precipitated with 3 volumes of ethanol in the presence of 0.3 M sodium acetate,
pH 5.2. The pellets were dissolved in 25 l of 20 mM sodium phosphate buffer
containing 130 mM NaCl (PBS; pH 8.0) supplemented with 3% SDS, incubated
for 2 min at 96°C followed by 10 min at 70°C, and allowed to cool to room
temperature. Triton X-100 was added to a final concentration of 5%. The volume
was adjusted to 375 l with PBS containing 0.5 mM dithioerythritol. Prior to
primer extension analysis, 12 pmol of the sample was subjected to immunopre-
cipitation (see below) and 2 pmol was directly digested with proteinase K,
extracted with PCI, precipitated twice with ethanol, and dissolved in CE buffer.
Immunoprecipitation of RNA-protein cross-links. Polyclonal rabbit antibodies
directed against a given U2 snRNP-specific protein were bound to protein
A-Sepharose beads. After being washed with PBS, the antibody-bound beads
were incubated with PBS containing 50 g/ml yeast tRNA, 0.5 mg/ml bovine
serum albumin, and 0.01% NP-40 for 2 h. Beads were subsequently washed three
times with PBS and incubated for 1 h at 4°C with UV cross-linked or non-cross-
linked 17S U2 snRNPs that had been disrupted by heating at 96°C in the
presence of 3% SDS (see above). After being washed extensively with PBS, beads
were incubated with 2 PK buffer for 5 min at 95°C and then diluted with an
equal volume of water. Proteins were digested on the beads with proteinase K
(end concentration of 0.5 mg/ml) for 1 h at 42°C. The RNA and peptide-RNA
cross-linked species were extracted with PCI, precipitated twice with ethanol,
and dissolved in CE buffer.
Primer extension analysis. Oligodeoxynucleotide primers complementary to
positions 77 to 97 (k91), 97 to 117 (J1), or 149 to 169 (k31) of the human U2
snRNA were 32P labeled at their 5 end by use of T4 polynucleotide kinase, and
1 to 2  105 cpm of primer was added to U2 snRNA-containing samples. The
samples were denatured by heating at 96°C for 1 min, allowed to anneal by
cooling to room temperature, and reverse transcribed with 1.5 U of AMV reverse
transcriptase (USB) per reaction for 50 min at 42.5°C. Sequencing ladders were
obtained from in vitro-transcribed U2 RNA under identical conditions except
that 0.5 mM dideoxynucleoside triphosphates were added. Reverse transcripts
were separated on an 8.3 M urea–9.6% polyacrylamide sequencing gel and
visualized by autoradiography.
RESULTS
To learn more about the molecular architecture of the 17S
U2 snRNP, we examined RNA-protein interactions within this
particle by lead(II) cleavage footprinting and direct UV cross-
linking. For this purpose, native human 17S U2 snRNPs were
immunoaffinity-purified from HeLa nuclear extract using anti-
SF3a120 monoclonal antibodies bound to protein G-Sepharose.
Particles were eluted under native conditions with an excess of
cognate peptide, and their RNA and protein compositions
were analyzed. As shown in Fig. 1, highly pure U2 snRNPs
could be isolated, as evidenced by the presence of almost
exclusively U2 snRNA in the eluate (Fig. 1A), and they possess
the same protein composition—as evidenced by SDS-PAGE
(Fig. 1B) and mass spectrometry (not shown)—as human 17S
U2 snRNPs previously immunoaffinity purified with anti-
SF3a66 antibodies (55). Importantly, immunoaffinity-purified
17S U2 snRNPs exhibited a homogeneous sedimentation be-
havior during glycerol gradient centrifugation, with nearly all
particles sedimenting in fractions 13 to 15 (Fig. 1C), which
correspond to the 17S region of the gradient.
Lead(II)-induced cleavage of U2 snRNA. Previous structure
probing of the human 17S U2 snRNP was limited to chemical
probing with DMS and kethoxal (2). To obtain more informa-
tion about the secondary structure of the U2 snRNA and those
nucleotides that might be involved in RNA-protein interac-
tions within the 17S U2 snRNP, we compared the lead(II)-
induced RNA cleavage pattern of naked U2 snRNA and U2
snRNA within native 17S U2 particles. Lead(II) cations induce
cleavages of RNA molecules in single-stranded and bulged
regions that are not spatially constrained or protected by pro-
teins (4). The reactivity of the sugar-phosphate backbone of
naked U2 snRNA towards lead(II), as determined by reverse
FIG. 1. Characterization of immunoaffinity-purified human 17S U2
snRNPs. (A and B) The RNA (A) and protein (B) compositions of 17S
U2 snRNPs immunoaffinity purified with antibodies against SF3a120
were analyzed by denaturing and SDS-PAGE, respectively. RNA was
visualized by silver staining and protein by staining with Coomassie
blue. The identity of RNA or protein is shown on the right. NE,
nuclear extract. (C) Purified 17S U2 snRNPs were fractionated on a
10% to 30% glycerol gradient, and the RNA composition of odd-
numbered and bottom gradient fractions (as indicated above) was
determined as described for panel A.
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FIG. 2. Lead(II)-induced cleavage of native human 17S U2 snRNPs. (A and B) Isolated U2 snRNA (RNA; lanes 1 to 4) or immunoaffinity-
purified 17S U2 snRNP (RNP; lanes 5 to 8) was probed with increasing concentrations of lead(II) acetate (0, 5, 15, and 45 mM; lanes 1 to 4 and
5 to 8). Cleavage sites were assayed by primer extension using oligonucleotides complementary to nt 97 to 117 (A) or 149 to 169 (B) and were
visualized by autoradiography. A sequencing ladder (on the left or right) was obtained by primer extension of in vitro-transcribed U2 RNA in the
presence of dideoxynucleotides. Those nucleotides that are strongly cleaved in the naked RNA are indicated by arrows to the right of lane 4.
Regions of U2 snRNA with increased or strongly reduced reactivity towards lead(II) when probed in the 17S U2 snRNP are marked by an open
or closed bar, respectively. Positions of the nucleotides are shown on the right of each panel. (C) Schematic representation of the comparative
reactivity of U2 snRNA in the purified 17S U2 snRNP versus isolated U2 snRNA. Increased reactivity towards lead(II) of U2 in 17S U2 snRNPs
compared to the results seen with isolated U2 snRNA is indicated by open arrowheads and weakly and strongly decreased reactivity by small and
large black boxes, respectively. The degree of reactivity was determined by eye by comparing the relative intensity of the bands in the RNA versus
RNP lanes, also taking into account the intensity of background in the absence of lead(II). The branch site-interacting region (BSiR) is highlighted
by a bar above the corresponding nucleotides, and the Sm site is underlined.
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transcription with primers complementary to positions 97 to
117 and 149 to 169 of U2 snRNA, is shown in Fig. 2A and B.
Regions efficiently cleaved in the presence of lead(II) (indi-
cated by closed arrows to the right of lane 4 in Fig. 2A and B),
as evidenced by greatly enhanced reverse transcription stops
(lanes 2 to 4) relative to the control reaction without lead(II)
(lane 1), included nucleotides located in (i) the loop of SLI
(U17-Gm19) or just upstream of SLIIa (C45-U46), (ii) stem
IIa (U49-C50), (iii) the loop of SLIIa (A56), (iv) the region
between SLIIa and SLIIb (G63-G68), (v) the loop of SLIIb
(A75-C78), (vi) the Sm site (U100-U104), (vii) the loop or
bulge of SLIII (U129-G131 and C135-G136), and (viii) a trinu-
cleotide downstream of it (A145-G147). Weakly accessible po-
sitions included nucleotides at the 5 end of U2, comprising the
stem of SLI, at or near the U2 branch site-interacting region,
in loop IIa, at the base of SLIIb and directly downstream of it,
and several nucleotides just upstream or within SLIII. The
overall cleavage pattern is in good agreement with the previ-
ously proposed secondary structure of U2 snRNA (1) (Fig.
2C), as the most reactive sites (with the exception of several
nucleotides in the stems of SLIIa and SLIIb) are located in
single-stranded regions.
When 17S U2 snRNPs were subjected to lead(II) cleavage,
U2 snRNA showed an altered reactivity compared to naked
U2 snRNA (Fig. 2A and B, lanes 5 to 8). The comparative
analysis of lead(II)-induced cleavage of naked U2 snRNA ver-
sus U2 in 17S U2 RNPs is schematically summarized in Fig.
2C. Cleavage of nucleotides in the branch site-interacting re-
gion, SLIIa, as well as in loops IIb and III was greatly reduced
or even abolished in the case of the Sm site (Fig. 2B; indicated
by solid bars to the right of lane 8). Other regions of U2
snRNA weakly reactive in the naked RNA were also less effi-
ciently cleaved in the 17S U2 snRNP, including the 5 end of
U2 and SLI. These results suggest either that RNA was directly
protected by the presence of proteins in these regions or that
its structure was altered (e.g., the formation of base pairs was
stabilized) via the interaction with proteins. Interestingly, se-
quences adjacent to the Sm site (nucleotides 94 to 98 and 110
to 112) were more susceptible to lead(II)-induced cleavage
(marked by open bars in Fig. 2B). Taken together, these results
suggest that multiple regions of the U2 snRNA are likely
contacted by protein in the 17S U2 snRNP.
Mapping of RNA-protein interaction sites via UV cross-
linking. To more precisely map the RNA-protein interaction
sites in native human 17S U2 snRNPs, we performed direct
UV cross-linking, followed by immunoprecipitation and primer
extension analysis as described previously (44). Exposure to
254-nm UV light is known to induce direct (zero-length) cross-
links between nitrogenous bases of nucleic acids and amino
acid side chains when they are in a favorable configuration.
First we analyzed UV cross-links in native 17S U2 snRNPs
purified from HeLa cell nuclear extract (“RNP” lanes), as well
as in the naked U2 snRNA (“RNA” lanes) extracted from 17S
U2 particles under mild conditions, which should preserve the
native secondary structure of the RNA. Putative RNA-protein
contact sites were determined by comparing the patterns of
reverse transcription (Fig. 3 and 4, lanes 1 to 4). Cross-linked
nucleotides interfere with primer extension. Therefore, strong
reverse transcriptase stops induced upon UV irradiation that
are present in the “RNP” lanes but absent or less intense in
“RNA” lanes should indicate the position of RNA-protein
cross-links, with an actual interaction site situated 1 nucleotide
upstream from the stop site. In contrast, stops that appear
irrespectively of UV irradiation are naturally occurring reverse
transcriptase stops and do not result from protein cross-links.
For example, major naturally occurring stops were consistently
observed at nucleotides 30 to 31, 48, 62, 66, 136, 140, and 145
(Fig. 3 and 4).
A number of putative RNA-protein cross-links could be
discerned. Enhanced reverse transcriptase stops were observed
at nucleotides C3 and 7, in SLI (i.e., at nucleotides U9-
Gm11, U16-Gm19, and A23), in the branch point-interacting
region (A35 and 38) and just downstream of it (41 and
Um47), in SLIIa (U55, A56, and U62), in loop IIb (A75, U76,
and C78), upstream of and at the Sm site (A88, A90, U92, A93,
U101, and U103), and in SLIII (A123, C128, U130, G131, and
C135) (Fig. 3A and B and 4A and B [cf. lanes 1 and 3]; please
note that the order of the RNA and RNP lanes is reversed in
Fig. 3B). Thus, proteins are potentially cross-linked one nucle-
otide upstream of these sites in the 17S U2 snRNP (see Fig. 5
for summary). Some of these stops were enhanced in the UV-
irradiated versus nonirradiated, naked U2 snRNA (e.g., U17
or A56) (Fig. 3A and 4A [cf. lanes 3 and 4]), and thus they
could alternatively represent RNA-RNA cross-links, due to
either long-range internal RNA interactions or the formation
of pyrimidine dimers. As the most downstream primer that we
used annealed to positions 149 to 169, no information about
protein-RNA contact sites downstream of C149 was obtained.
Taken together, these data indicate that the U2 snRNA is
contacted at multiple positions apparently over its entire
length by proteins.
Identification of the protein-RNA cross-links within the U2
snRNA Sm site. To identify proteins contacting the U2
snRNA, cross-linked RNA-protein species were immunopre-
cipitated with antibodies against a subset of 17S U2 snRNP
proteins, including SmG and SmB, all SF3a subunits (SF3a60,
SF3a66, and SF3a120), and several SF3b proteins (i.e., SF3b14a/
p14, SF3b49, SF3b145, and SF3b155). These antibodies re-
acted specifically with their cognate proteins on immunoblots
containing HeLa nuclear extract proteins (data not shown).
Precipitated cross-links were subsequently identified by primer
extension analysis. Prior to immunoprecipitation, 17S U2 snRNPs
were disrupted by incubating at 96°C in the presence of 3%
SDS (for details, see Materials and Methods). Under these
conditions, only SF3b49, SF3b14a/p14, or SF3a60, and no
other U2 proteins (as evidenced by silver staining after SDS-
PAGE), were precipitated with anti-SF3b49, anti-SF3b14a/p14,
or anti-SF3a60 antibodies, respectively, that were covalently cou-
pled to protein A-Sepharose, indicating that the vast majority of
U2 snRNPs and their subcomplexes had been dissociated (data
not shown). Furthermore, U2 RNA from the nonirradiated U2
snRNP samples was not precipitated by any of the antibodies
that were tested (Fig. 3 and 4 and data not shown), further
indicating that all non-cross-linked, protein-RNA interactions
had been disrupted and also did not reform during immuno-
precipitation.
UV irradiation generated at least two RNA-protein cross-
links within the Sm site at positions U100 and U102 (Fig. 3B
and 4B [cf. lanes 1 and 3]). Primer extension analysis of cross-
links immunoprecipitated with anti-SmG antibodies revealed
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that they precipitated nearly exclusively the cross-link at U100
(i.e., a major reverse transcriptase stop at U101 was observed)
(Fig. 3B, lane 7), confirming that SmG contacts this site. Sim-
ilarly, the cross-link at U102 was highly enriched in the anti-
SmB/B immunoprecipitate, indicating that it is contacted by
SmB/B (Fig. 3B, lane 9). These data are in accordance with
previous UV cross-linking studies performed with a short oli-
gonucleotide derived from the Sm site of the U4 snRNA,
which indicated that the first and third residues of the Sm site
are contacted by SmG and SmB/B, respectively (45).
FIG. 3. Identification of UV-induced U2 snRNA-protein cross-linking sites within native human 17S U2 snRNPs. (A) Primer extension
analyses of U2 snRNA extracted from UV-irradiated (lane 1) or nonirradiated (lane 2) immunoaffinity-purified 17S U2 snRNPs (RNP) and
UV-irradiated (lane 3) or nonirradiated (lane 4) naked U2 snRNA (RNA). (B) Primer extension analyses of UV-irradiated (lane 1) or
nonirradiated (lane 2) naked U2 snRNA or U2 snRNA extracted from UV-irradiated (lane 3) or nonirradiated (lane 4) immunoaffinity-purified
17S U2 snRNPs (RNP). Immunoprecipitation (IP) with anti-SF3b49, anti-SmG, anti-SmB/B, or anti-SF3a66 antibodies (as indicated above each
lane), followed by primer extension analyses, was performed after denaturation of UV-irradiated (lanes 5, 7, and 9) or nonirradiated (lanes 6, 8,
and 10) 17S U2 snRNPs. Primer extension was performed with oligonucleotides complementary to nt 77 to 97 (A) and 149 to 169 (B). Dideoxy
sequencing markers were generated as described for Fig. 2. Nucleotide positions are shown on the left. Reverse transcriptase stops due to putative
RNA-protein cross-links (closed circles), specific protein-RNA cross-links (open diamonds), potential RNA-RNA cross-links (asterisks), and
major background stops (squares) are indicated.
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SF3a60 contacts SLI and SLIII of the U2 snRNA. Anti-
SF3a60 antibodies precipitated multiple U2 cross-link species,
including some not readily apparent in the input irradiated
RNP lane (Fig. 4A and B [cf. lanes 1 and 7]). Several of these,
including U16-U18, 34, 37, U55, Cm61, U92, and U100,
were precipitated equally well by other antibodies and were
not clearly enriched in the anti-SF3a60 immunoprecipitate
(Fig. 3 and 4). Thus, they could not unequivocally be desig-
nated as SF3a60 cross-links. The precipitation of multiple
cross-links by several antibodies might be due to cross-linking
of two different proteins to the same RNA molecule or arise
from incomplete disruption or reassociation of a small fraction
of the U2 particles during immunoprecipitation. However, six
cross-links were either specifically precipitated by anti-SF3a60
antibodies (i.e., C8-U9 and U22-A23 within SLI as well as C28
downstream of it) or they were significantly enriched relative to
FIG. 4. Identification of protein-RNA contact sites within native human 17S U2 snRNPs. (A and B) Primer extension analyses of U2 snRNA
extracted from UV-irradiated (lane 1) or nonirradiated (lane 2) immunoaffinity-purified 17S U2 snRNPs (RNP) and UV-irradiated (lane 3) or
nonirradiated (lane 4) naked U2 snRNA (RNA). Immunoprecipitation (IP) with anti-SF3b14a/p14 (lanes 5 to 6) or anti-SF3a60 (lanes 7 to 8)
antibodies, followed by primer extension analyses, was performed after denaturation of UV-irradiated (lanes 5 and 7) or nonirradiated (lanes 6
and 8) 17S U2 snRNPs. Primer extension was performed with oligonucleotides complementary to nt 77 to 97 (A) and 149 to 169 (B) and visualized
by autoradiography. Dideoxy sequencing markers were generated as described for Fig. 2. Nucleotide positions are shown on the left. Reverse
transcriptase stops due to putative RNA-protein cross-links (closed circles), specific protein-RNA cross-links (open diamonds), potential RNA-
RNA cross-links (asterisks), and major background stops (squares) are indicated.
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the input cross-linked material (i.e., U122 in the internal loop
of SLIII). All other bands observed by primer extension anal-
ysis (e.g., Gm12, m6Am30, G31, and 41) represented natu-
rally occurring reverse transcriptase stops. Our results demon-
strate that SF3a60 contacts U2 snRNA nucleotides in SLI and
SLIII within the U2 snRNP and thus bridges distant regions of
the RNA molecule (see Fig. 5 for a summary of cross-links).
In contrast, U2 snRNA from irradiated particles was not
immunoprecipitated with anti-SF3a66 antibodies (Fig. 3A,
lanes 7 and 8, and data not shown). As the cognate SF3a120
peptide used to elute U2 snRNPs could hinder subsequent
immunoprecipitation by anti-SF3a120 antibodies, to test for
SF3a120-RNA interactions 17S U2 snRNPs were isolated us-
ing anti-SF3a66 antibodies as described previously (55). Im-
portantly, identical cross-linking patterns were observed with
17S U2 snRNPs purified with both antibodies (data not shown)
and none of the cross-links were immunoprecipitated with the
anti-SF3a120 antibodies (data not shown). Thus, SF3a120 and
SF3a66 either (i) do not contact the U2 snRNA directly or (ii)
contact U2 but are in a conformation that does not favor the
formation of UV-induced cross-links or their respective epitopes
are not accessible, preventing immunoprecipitation. Taken to-
gether, these results suggest that SF3a contacts the U2 snRNA
primarily via its 60-kDa subunit.
SF3b14a/p14 contacts U2 snRNA close to the branch site-
interacting region. Anti-SF3b14a/p14 antibodies also precipi-
tated a number of putative cross-links. Comparison of the
primer extension patterns of U2 snRNAs recovered from the
UV-irradiated 17S U2 snRNP before (“RNP”; Fig. 4, lanes 1)
and after (lanes 5) immunoselection with SF3b14a/p14-specific
antibodies revealed that the cross-link at G31 is clearly en-
riched in the immunoprecipitated fraction. Moreover, in con-
trast to the other immunoprecipitated species, this cross-link
was not precipitated by any of the other antibodies tested. This
indicates that G31, which is located only a few nucleotides
from the pre-mRNA branch site-interacting region of U2, is
contacted by SF3b14a/p14. These data are consistent with pre-
vious reports demonstrating that SF3b14a/p14 is directly cross-
linked to the branch point adenosine in the context of the
spliceosomal A complex where U2 is engaged in base-pairing
interactions with the pre-mRNA’s BPS (36).
SF3b49 makes multiple contacts with the U2 snRNA. The
primer extension analysis of the cross-linked U2 snRNAs im-
munoprecipitated with anti-SF3b49 antibodies from the UV-
irradiated native U2 particles generated a complex pattern
(Fig. 3A and B, lanes 5 and 6). SF3b49-specific cross-links—
i.e., those precipitated exclusively by anti-SF3b49 antibodies—
were detected at the 5 end of U2 snRNA (Am1, Um2, and
6) and in SLIIb (U74 and A75) (Fig. 3A and B, lanes 5). The
most prominent cross-links precipitated by anti-SF3b49 anti-
bodies were to nucleotides U18 (in loop I) and 91-U92 (up-
stream of the Sm site), with the former being significantly
enriched after immunoprecipitation with anti-SF3b49
antibodies (Fig. 3A and B [cf. lanes 1 and 5]). The 91-U92
cross-links, as well as several other cross-links precipitated by
anti-SF3b49 antibodies (e.g., U55 and Cm61 [cf. Fig. 4A, lanes
5 and 7]), were also precipitated by other antibodies, and thus
they cannot be unequivocally identified. Others (i.e., U100 and
U122) clearly represent cross-links with other U2 proteins, as
U101 and A123 were the strongest reverse transcriptase stops
observed after immunoprecipitation with anti-SmG and anti-
SF3a60 antibodies, respectively (Fig. 3B, lane 7, and Fig. 4B,
lane 7). Anti-SF3b155 and anti-SF3b145 antibodies precipi-
tated only very small amounts of U2 snRNA from irradiated
17S U2 snRNPs; thus, a detailed analysis was difficult, as the
respective primer extension patterns were very weak (data not
shown). However, most discernible stops coincided with strong
natural reverse transcriptase stops and no enrichment of any
particular stop was observed after immunoprecipitation with
these antibodies. Taken together, these data suggest that
SF3b49 makes multiple contacts with the U2 snRNA, including
its extreme 5 end and the loop of SLIIb (Fig. 5). Thus, it may
be a major determinant for tethering SF3b to the U2 snRNP.
FIG. 5. Summary of U2 snRNA-protein cross-links revealed by immunoprecipitation and primer extension analyses. BSiR, branch site-
interacting region.
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SF3b49 interacts with the 5 end of U2 snRNA in reconsti-
tuted 17S U2 snRNPs. To obtain independent evidence that
SF3b49 contacts nucleotides at the very 5 end of the U2
snRNA, we performed UV cross-linking with in vitro-recon-
stituted U2 snRNPs. Previous reports indicated that modifica-
tions within the first 24 nucleotides of the human U2 snRNA
are essential and sufficient for its activity in splicing (11). We
thus prepared a chimeric U2 snRNA by ligating together a
synthetic oligonucleotide, 32P labeled at its 5 end, that encom-
passes the 5 terminal 24 nucleotides of the U2 snRNA and
contains all modifications (Fig. 6A), with an unmodified in vitro-
transcribed RNA comprising the remaining part of U2. This
chimeric U2 RNA was first incubated with purified total
snRNP proteins to form 12S U2 snRNPs and later with HeLa
nuclear extract specifically depleted of 12S U2 snRNPs to
generate 17S U2 snRNPs (38). U2 snRNPs reconstituted in
this way support pre-mRNA splicing in U2-depleted HeLa
nuclear extract and thus are functionally active (11).
Reconstituted U2 particles were UV irradiated and treated
with RNase T1 to generate a radiolabeled fragment comprising
solely the first four nucleotides of U2, thereby allowing us to
identify proteins cross-linked to nucleotides 1 to 4 of U2
snRNA. Gel analysis of the digested RNA revealed that more
than 95% of the U2 RNA had been digested to completion
(data not shown), with only a small amount of a partially
digested fragment observed (Fig. 6B). A double band migrat-
ing at 50 kDa on SDS-polyacrylamide gels was observed
upon UV irradiation of 17S U2 snRNPs but not in the absence
of UV (Fig. 6B [cf. lanes 1 and 2]). This cross-link was sensitive
to proteinase K and was not observed with in vitro-reconsti-
tuted 12S U2 snRNPs or naked U2 snRNA (data not shown),
suggesting that it was a cross-link between the SF3b49 protein
and U2 snRNA. To determine the identity of the cross-linked
protein, immunoprecipitations were performed with anti-SF3b49
and anti-SF3a60 antibodies after disruption of RNP complexes
as described above. This cross-linked species was precipitated
solely by anti-SF3b49 antibodies (Fig. 6B, lanes 3 to 6), con-
firming that it contains SF3b49. Note that the cross-link mi-
grated faster and appeared as a single band after immunopre-
cipitation, most likely due to the presence of large amounts of
heavy chain immunoglobulin G in the lanes. These results
corroborate our cross-linking data obtained with native 17S U2
snRNPs, according to which SF3b49 could be cross-linked to nt
Am1 and Um2 and thus provide independent evidence that the
SF3b49 protein contacts the 5 end of the U2 snRNA.
RNA-protein cross-linking in spliceosomal A and B com-
plexes. Next we addressed whether rearrangements occur in
protein-RNA interactions within the U2 snRNP upon its inte-
gration into the spliceosomal A complex and/or upon the sub-
sequent integration of the U4/U6.U5 tri-snRNP during B com-
plex formation. For this purpose, spliceosomal complexes were
purified using aptamer-tagged, adenovirus-derived MINX pre-
mRNA and a tobramycin affinity selection method (18) fol-
lowed by glycerol gradient centrifugation. Gradient fractions
11 to 12 were enriched in complex A (as evidenced by the
nearly equimolar amounts of pre-mRNA and U1 and U2 snRNA),
and fractions 15 to 16 contained predominantly complex B (as
evidenced by the nearly equimolar amounts of pre-mRNA and
U1, U2, U4, U5, and U6 snRNA) (Fig. 7A). B complexes were
also isolated using an MS2 affinity purification method and a
MINX pre-mRNA containing MS2 binding sites (9). After
incubation with HeLa nuclear extract under splicing condi-
tions, spliceosomal complexes were separated by glycerol gra-
dient centrifugation, and the B complex peak was further pu-
FIG. 6. Identification of proteins cross-linked to the 5 end of U2
snRNA in 17S U2 snRNPs reconstituted in vitro. (A) Schematic rep-
resentation of the chimeric U2 snRNA prepared by ligation of a
32P-5-end-labeled synthetic oligoribonucleotide, corresponding to the
first 24 nucleotides of human U2 snRNA (shown in black), to in
vitro-transcribed U2 encompassing nucleotides 25 to 187 (shown in
gray). The radioactive label (asterisk) and the 5-most RNase T1 cleav-
age site (arrowhead) are indicated. The 4-nt-long radioactive fragment
of U2 generated by complete RNase T1 digestion of U2 snRNA is
underlined. (B) 17S U2 snRNP particles were in vitro reconstituted
with the chimeric U2 snRNA and subjected to UV irradiation (lanes 1,
3, and 5). U2 snRNPs in the even-numbered lanes and in lane 7 were
not irradiated. All samples (except the lane 7 sample) were digested by
RNase T1 and either directly analyzed by SDS-PAGE (“input”; lanes
1 and 2) or after immunoprecipitation with anti-SF3b49 (lanes 3 and 4)
or anti-SF3a60 (lanes 5 and 6) antibodies. Protein-RNA cross-linked
species were visualized by autoradiography. The positions of full-
length U2, the SF3b49-U2 snRNA cross-link, and partially digested U2
snRNA are indicated by closed arrowheads on the right; note that the
32P-labeled 4-nt fragment has run out of the gel. The positions of
molecular mass markers are shown on the left.
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FIG. 7. Identification of U2 snRNA-protein cross-links in purified native spliceosomal A and B complexes. (A) RNA composition of
affinity-purified spliceosomal complexes. RNA was isolated from tobramycin affinity-selected A (lane 1) or B (lane 2) complexes, or MS2
affinity-selected B complexes (lane 3), fractionated on a 7 M urea–10% polyacrylamide gel and visualized by silver staining. The position of the
snRNAs or pre-mRNA is indicated on the right. (B and C) Primer extension analyses of UV-irradiated (lanes 1 and 3) or nonirradiated (lanes 2
and 4) naked U2 snRNA (RNA) isolated from purified spliceosomal B complexes or 17S U2 snRNPs (as indicated above each lane) or U2 snRNA
extracted from UV-irradiated (lanes 5, 7, 9, and 11) or nonirradiated (lanes 6, 8, 10, and 12) affinity-purified A complex, B complex, or 17S U2
snRNPs (RNP), as indicated above each lane. B complexes isolated via the tobramycin affinity method are designated “B,” whereas those isolated
via MS2 affinity selection are labeled “B.” Primers complementary to nt 97 to 117 (A) and 149 to 169 (B) were used, and primer extension products
were visualized by autoradiography. Dideoxy sequencing markers were generated as described for Fig. 2. Nucleotide positions are shown on the
left. RNA-protein cross-links present in isolated 17S U2 snRNPs but reduced in the purified spliceosomal A and B complexes (closed ovals) or
cross-links observed in purified A and B complexes but not observed in free 17S U2 snRNPs (open oval) are indicated.
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rified by binding to an amylose column and eluting with
maltose. Native B complexes purified in this way also con-
tained equimolar amounts of pre-mRNA and U1, U2, U4, U5,
and U6 snRNA (Fig. 7A) and all major protein components
(e.g., SF3a and SF3b) of the 17S U2 snRNP (J. Deckert, H.
Urlaub, K. Hartmuth, and R. Lu¨hrmann, unpublished data).
A and B complexes were irradiated with 254 nm UV light,
and cross-links to U2 snRNA were analyzed as described
above. The overall U2 cross-linking patterns of gradient frac-
tions 11 to 12 (A complex) and 15 to 16 (Tobra-B complex) as
well as MS2 affinity-purified complex B were very similar to
that observed for 17S U2 snRNP with the most prominent
cross-links to nt 16, 55, 61, 92, 100, 102, and 122 (Fig. 7B and
C, lanes 5 to 12). Thus, a global rearrangement in RNA-
protein interactions within the U2 snRNP does not appear to
occur during A and B complex assembly. However, clear dif-
ferences in RNA-protein cross-links in the 5 part of U2 were
observed. That is, cross-links to nt C8 and U9 (contacted by
SF3a60 in U2 snRNPs), as well as to 34 and 37 (contacted
by unidentified proteins), were greatly reduced in both A and
B complexes compared to 17S U2 snRNP (Fig. 7B and C,
closed circles). In addition, a novel cross-link to uridine 32
(open circle in Fig. 7B) appeared in both A and B complexes.
Intriguingly, some of these changes appear in the functionally
important regions of the U2 snRNA, which are known to
interact with the BPS of the pre-mRNA earlier in the A com-
plex and later with the U6 snRNA in complex B or B* (acti-
vated spliceosomes) (reference 28; for a review, see reference
31). Immunoprecipitation of UV-irradiated, purified spliceo-
somal A and B complexes with anti-SF3a60 antibodies con-
firmed that SF3a60 contacted U122 in all complexes tested
whereas C8 and U9 were efficiently cross-linked to SF3a60 only
in 17S U2 snRNPs (data not shown). Due to the limited
amount of material available for immunoprecipitations, it was
not possible to identify the protein cross-linked to U32 of the
U2 snRNA in the A and B spliceosomal complexes. Taken
together, these results indicate that a rearrangement in the
RNP architecture of the 5 end of the U2 snRNP occurs early
during A complex formation, when U2 first stably associates
with the BPS.
DISCUSSION
Here we have investigated RNA-protein contact sites in the
immunoaffinity-purified human 17S U2 snRNP via lead(II)-
induced RNA cleavage and UV cross-linking studies. A num-
ber of cross-linked proteins, including SF3b49, SF3a60, and
SF3b14a/p14, as well as their contact sites could be precisely
assigned by performing cross-linking followed by immunopre-
cipitation. A similar analysis was carried out with affinity-pu-
rified spliceosomal A and B complexes. Data presented here
provide much-needed information regarding the molecular ar-
chitecture of the 17S U2 snRNP. They also provide insight into
the dynamics of RNA-protein interactions within this spliceo-
somal subunit upon its stable integration into the A complex
(i.e., prespliceosome) and during the subsequent conversion of
the latter into the B complex (i.e., mature spliceosome).
Multiple protein-RNA contacts within the 17S U2 snRNP.
Our lead(II)-induced RNA cleavage experiments provide ini-
tial evidence of how U2-associated proteins are positioned on
the U2 snRNA. Generally, the reactivity of most regions of the
U2 snRNA was greatly reduced when 17S U2 snRNPs were
probed compared to the results seen with naked RNA isolated
from these particles, suggesting that the U2 snRNA makes
multiple contacts with protein (Fig. 2). This is consistent with
the large number of U2-associated proteins known to be asso-
ciated with the 17S U2 snRNP (55) and previous studies re-
vealing that most regions of the U2 snRNA within the U2
snRNP are resistant to nuclease treatment (25). Our UV cross-
linking studies subsequently revealed numerous RNA-protein
contacts throughout the U2 snRNA (Fig. 5), providing further
evidence that the U2 snRNA is well protected by protein in the
17S U2 snRNP. As expected, nucleotides U100 to U105
located within the Sm site were completely protected from
lead(II) cleavage, presumably due to the highly stable associ-
ation of the Sm proteins with the Sm site. In agreement with
previous structure probing and nuclease protection data, we
also observed somewhat increased reactivity of RNA in the 17S
U2 snRNP in those regions bordering the Sm site (17, 25). A
decrease in the lead(II)-induced cleavage of the branch site-
interacting region of the U2 snRNA was also observed, indi-
cating that proteins contact the sugar-phosphate backbone of
this region of U2. Such contacts would theoretically still allow
for subsequent base-pairing interactions between U2 and the
pre-mRNA BPS within the spliceosome and may even pro-
mote this interaction.
Sm protein-Sm site interactions are conserved. Using a
combination of UV cross-linking and immunoprecipitation
(44), we were able to assign a number of the cross-linking sites
to specific proteins. Consistent with previous studies with pu-
rified U1 snRNPs and in vitro-reconstituted Sm core RNPs
(20, 45), two major cross-linking sites involving the SmG and
SmB proteins were observed within the Sm site of the immu-
noaffinity-purified U2 snRNP (Fig. 3). In particular, immuno-
precipitation studies revealed contacts between U100 and
U102 (i.e., the first and the third uridines of the Sm site) and
the SmG and SmB/B proteins, respectively. These data pro-
vide additional evidence that Sm protein-Sm site interactions
are conserved among the spliceosomal snRNPs.
SF3b14a/p14 is favorably positioned for its interaction with
the BPS. Interestingly, a contact site between SF3b14a/p14 and
the U2 snRNA was mapped to G31, which is located just two
nucleotides upstream of the branch site-interacting region (nt
33 to 38) of the U2 snRNA (Fig. 4). This region of U2 base
pairs with the BPS of the pre-mRNA, resulting in a duplex in
which the branch point adenosine is bulged out (35). SF3b14a/
p14 was shown to contact this adenosine during early spliceo-
some assembly (i.e., in the A complex) and to remain attached
to it through at least the first catalytic step of splicing (26, 36,
53). Due to its close contact with the BPS, it is suspected to
play a crucial role in positioning the U2 snRNP on the pre-
mRNA and in the first catalytic step of the splicing reaction.
Our data indicate that early within the 17S U2 snRNP,
SF3b14a/p14 is favorably positioned for its subsequent inter-
action with the branch point adenosine upon association of the
U2 snRNP with the pre-mRNA’s BPS.
SF3b14a/p14 is comprised predominantly of a single RRM,
and RNA binding studies with isolated SF3b14a/p14 revealed
that it possesses general nucleic acid binding activity but does
not specifically recognize U2 snRNA or the BPS or their
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duplex on its own (39). As high-affinity binding of SF3b14a/p14
to a U2 oligonucleotide comprising the branch site-interacting
region was not observed in the aforementioned studies, it
would appear that SF3b14a/p14 is not the main determinant
for tethering other SF3b proteins to the U2 snRNP. Our cross-
linking studies with purified A and B complexes did not pro-
vide clear information as to whether or not SF3b14a/p14 re-
mains in contact with G31 of the U2 snRNA in spliceosomal
complexes where it has been shown to contact the branch point
adenosine. Thus, it is presently not clear whether SF3b14a/p14
contacts simultaneously both the pre-mRNA and the U2
snRNA within the spliceosome. Interestingly, a novel uniden-
tified cross-link at U32 of U2 was observed in these complexes
and could thus potentially be SF3b14a/p14. However, addi-
tional studies are required to clarify this point.
SF3a60 contacts SLI and SLIII of the U2 snRNA. Of the
three proteins comprising SF3a, we identified cross-links be-
tween U2 snRNA and SF3a60 only, suggesting that this protein
plays a key role in tethering SF3a to the U2 snRNP. In vitro
studies indicate that SF3a incorporation into the U2 snRNP
requires the prior assembly of a 15S U2 snRNP that contains
SF3b and components of the 12S U2 snRNP (i.e., the Sm
proteins and A/B) (25). In vitro reconstitution studies with
purified, individual SF3a subunits indicate that SF3a60 (as well
as the other SF3a proteins) can bind the 15S U2 snRNP on
their own (30). Deletion analyses revealed that association of
SF3a60 requires an intact zinc finger domain at its C terminus
(30), which is the only conserved motif found in SF3a60. Zinc
finger domains are known to bind nucleic acids; thus, it is
tempting to speculate that this region of SF3a60 contacts the
U2 snRNA. Taken together, our data indicate that the inter-
action of SF3a to form the 17S U2 snRNP is stabilized, at least
in part, by direct U2 snRNA-SF3a60 contacts.
In addition to contacting the bulge in SLIII, SF3a60 made
multiple contacts with the lower stem of SLI (Fig. 4). As
UV-induced RNA-protein cross-links are generally not formed
when nucleotides are engaged in base-pairing interactions, our
results suggest that within the U2 snRNP, the lower part of SLI
does not form. Likewise, previous structure-probing studies
suggested that the base of stem I is unpaired in 17S U2 snRNPs
(2). Formation of stem I is not essential, whereas its hyper-
stabilization has deleterious effects on splicing (56). Thus,
SF3a60, together with other U2 proteins such as SF3b49, which
was also cross-linked nearby, may help to maintain it in an
unpaired conformation. This in turn likely facilitates the base-
pairing interaction between this region of U2 and the U6
snRNA to form U2/U6 helix I and II, a crucial RNA structure
at the catalytic core of the spliceosome (see below for detailed
discussion).
SF3b49 makes multiple contacts with the U2 snRNA. Inter-
estingly, SF3b49 was found to contact U2 snRNA at multiple
sites, including its extreme 5 end and loops I and IIb. It
contains two N-terminal RRMs; thus, its domain structure
suggests that it should possess RNA binding activity. SF3b49
was shown to play a role in tethering the U2 snRNP to the BPS
during spliceosomal A complex assembly, contacting the pre-
mRNA just upstream of the BPS (15) and interacting with
another component of the U2 snRNP, the SF3b145 protein
(6). The Caenorhabditis elegans homologue of SF3b49 was
shown to bind RNA in vitro primarily via its RRM2 (43). In
yeast, the protein-protein interaction site of HSH49 and Cus1p,
the yeast homologues of the human SF3b49 and SF3b145 pro-
teins, respectively (49), was mapped to the first RRM of HSH49.
Further mutational analyses indicated that the RNA and pro-
tein binding surfaces of the RRM1 of HSH49 are most likely
distinct and that both RRMs are required for viability in yeast
(22). Based on the detection of multiple cross-links involving
SF3b49, it is likely that the observed cross-linking pattern (in-
volving different regions of the U2 snRNA) would require the
contribution of both RRMs. However, as cross-linking implies
close contact and not necessarily binding per se, regions other
than SF3b49’s RRMs could also be cross-linked.
The interactions of SF3b49 and SF3a60 with the 5 end of
the U2 snRNA (including SLI) described here might be of
primary importance for the integrity of 17S U2 snRNPs. That
is, it was observed previously that removal of 10 to 15 nucleo-
tides from the 5 end of U2 snRNA results in a loss of the
majority of proteins, changing the sedimentation value of the
particle to 10S to 12S (2). Thus, SF3b49 and SF3a60 could
potentially play a crucial role in tethering the SF3a/b com-
plexes to U2 snRNP. Within the spliceosome, SF3b49, as well
as SF3a60, contacts a relatively short region (about 25 nt) of
the pre-mRNA upstream of the BPS (6, 15, 40). As with
SF3b14a/p14, it is presently not clear whether these proteins
contact simultaneously both the pre-mRNA and the U2 snRNA
in spliceosomal complexes. However, as the U2 snRNA cross-
linking pattern in purified A and B complexes was nearly identical
to that in purified 17S U2 snRNPs (with notable exceptions at the
5 end of U2; see below), several SF3b49 and SF3a60 contacts
with the U2 snRNA (e.g., at nucleotides 74, 75, and 122) appear
to remain unchanged. Thus, it is likely that these proteins simul-
taneously contact the U2 snRNA and the pre-mRNA in the
vicinity of the BPS.
As SF3b is also a component of the U11/U12 snRNP, our
data may provide first insights into how SF3b is incorporated
into this snRNP particle. That is, it is likely that SF3b49 also
contacts the U12 snRNA within the U11/U12 snRNP. As the
sequences of U12 and U2 are essentially unrelated but the
general structures of their 5 halves are similar, SF3b49 could
be envisioned to bind in a sequence-independent manner to
analogous regions of the U12 snRNA. However, additional
studies (i.e., UV cross-linking of purified U11/U12 snRNPs)
are clearly required to answer this question.
Additional proteins likely contact the U2 snRNA. The pro-
tein moiety of a number of U2 snRNA-protein cross-links
could not be identified, due to lack of antibodies or the inac-
cessibility of the epitope recognized by the antibodies at hand
(Fig. 5). Thus, additional U2-associated proteins appear to
contact the U2 snRNA. Furthermore, some RNA-protein in-
teractions may have escaped detection, as only those in a
conformation favorable for UV cross-linking would be ob-
served. Indeed, previous studies suggested that SF3b145 con-
tacts the U2 snRNA. The cross-links to nucleotides Cm40 and
U46, as well as those to SLIIa, might be due to interactions
with SF3b145, as several genetic studies performed with yeast
linked this protein to these regions of the U2 snRNA (49, 57).
Likewise, Prp9-Prp11-Prp21 (the yeast homologues of SF3a60,
SF3a66, and SF3a120, respectively) and Prp5 were found to
genetically interact with nucleotides just upstream of SLIIa, as
well as with SLIIa and SLIIb, suggesting that these factors
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might bind to these regions of U2 (37, 48, 57). Finally, on the
basis of the U2 model presented by Kra¨mer et al. (25) (see
below), the cross-links in the loop of SLIII might involve
SF3a120 and/or SF3a66.
A more compact RNP structure for the 17 U2 snRNP? Pre-
vious biochemical and electron microscopy studies (2, 25) sug-
gested a model of 17S U2 snRNP organization in which SF3b
proteins interact with the 5 half of the U2 snRNA whereas the
Sm proteins, SF3a and U2-A/U2-B, bind to its 3 half and
form a second domain of the U2 snRNP. Consistent with this
model, two SF3b subunits (SF3b49 and SF3b14a/p14) were
cross-linked to the 5 part of the U2 snRNA (i.e., within nt 1 to
31) whereas one of the contact sites of SF3a60 was mapped to
the bulge in SLIII (Fig. 3 and 4). Intriguingly, a second site of
interaction with SF3a60 was found at the base of SLI, indicat-
ing that SF3a60 spans the 5 and 3 halves of the U2 snRNA.
Thus, the 17S U2 snRNP might have a more compact structure
than previously thought (2, 25). Indeed, electron microscopy
imaging of the 17S U2 particles used in this study revealed that
they predominantly have a globular shape (B. Sander, M. M.
Golas, C. L. Will, B. Kastner, H. Stark, and R. Lu¨hrmann,
unpublished data) rather than two smaller domains connected
with a thin filament (i.e., a dumbbell shape) as previously
reported (2, 25). This difference in appearance most likely
arises from the different purification conditions used in each
study and suggests that some of the interactions within the 17S
U2 snRNP are not particularly stable.
Evidence for U2 snRNP remodeling upon its stable integra-
tion into the spliceosome. Examination of U2 snRNA-protein
interactions in purified spliceosomal A and B complexes re-
vealed that the RNP structure involving the 5 end of the U2
snRNA undergoes a conformational change during spliceo-
some assembly. That is, cross-links to nucleotides 8 and 9 (SLI)
and to nucleotides 34 and 37 (branch site-interacting region)
were significantly reduced in both spliceosomal complexes
compared to the results seen with the free 17S U2 snRNP (Fig.
7). In contrast, enhanced cross-link formation was observed at
nucleotide 32 in spliceosomal complexes. The observed changes
were quantitative in nature (e.g., residual cross-linking to nt 8, 9,
34, and 37 was consistently observed), suggesting that the com-
plexes analyzed may be structurally heterogeneous or contain
small amounts of contaminating 17S U2 snRNPs. Nonetheless,
our data indicate that the U2 snRNP has already been remodeled
at the time of its stable interaction with the BPS of the pre-
mRNA.
Interestingly, the 5 end of the U2 snRNA is involved in an
extensive RNA network, formed by U2, U6, and the pre-
mRNA, that is essential for splicing (reviewed in reference 31).
While the U2 snRNA-BPS base-pairing interaction is known to
be first established during A complex formation (i.e., in the
prespliceosome), U2-U6 interactions occur after tri-snRNP
addition (after B complex formation). However, it is presently
not clear whether these interactions have already been estab-
lished in the B complex or occur only at the time of spliceo-
some activation (for a recent discussion, see reference 28). At
present, three different U2/U6 base-pairing interactions have
been reported: helix I, consisting of helix Ia and Ib separated
by two unpaired adenosines of U2 (27), helix II (19), and helix
III (42).
Intriguingly, the observed changes in the U2 snRNA cross-
linking pattern in spliceosomal complexes involve protein con-
tacts with nucleotides of U2 forming U2/U6 helix II (C8 and
U9) and nucleotides upstream (U32) or within the branch
point helix (34 and 37). Our finding that SF3a60 is bound
to nucleotides 8 and 9 of the U2 snRNA and that these con-
tacts are significantly reduced upon association of U2 with the
BPS in the A complex indicates that the RNP rearrangements
involve SF3a60. Immunoprecipitations with anti-SF3a60 anti-
bodies of the A and B complexes after UV irradiation showed
that this protein does not completely leave the U2 snRNP
(data not shown); thus, it likely remains attached to the bulge
in SLIII in spliceosomal complexes. As UV-induced RNA-
protein cross-links are typically not formed when nucleotides
are engaged in base-pairing interactions, it is currently not
clear whether the unknown protein(s) contacting 34 and 37
(which are base paired already in the A complex) are displaced
from the U2 snRNA or whether the relative protein-RNA
orientation was changed due to base-pairing interactions such
that cross-linking is prevented. Likewise, the loss of the C8 and
U9 cross-links in the purified B complexes could be due to the
formation of the U2/U6 helix II, which involves these nucleo-
tides. However, as the cross-links to C8-U9 disappear and the
cross-link to U32 has already appeared in the A complex, when
no U6 is present (18), these RNP rearrangements occur early
on and are not a consequence of U2/U6 helix formation. In-
deed, based on their location, one or more of these rearrange-
ments may facilitate or be a prerequisite for subsequently es-
tablishing U2/U6 base-pairing interactions. Even though the
identity of the protein(s) cross-linked to U32, 34, and 37
has not been determined, it is tempting to speculate that it is
SF3b14a/p14, which might “move” towards the branch point
adenosine, switching from G31 in the isolated 17S U2 snRNP
to U32 in the spliceosome.
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